文献速递心脑血管急症重症综合管理与镇静镇痛

缺血性卒中发病率、严重程度与卒中后认知下降及痴呆风险

Ischemic Stroke Incidence and Severity and Poststroke Cognitive Decline and Incident Dementia.
PubMed 文献 · JAMA Netw Open · 2026-04-01
一句话结论在3个美国前瞻性队列中,缺血性卒中后痴呆风险随卒中严重程度递增,NIHSS≥11者风险约为无卒中者的5倍,且整体认知、记忆与执行功能下降更快。

该研究汇总3个美国前瞻性队列(ARIC、Framingham后代研究、REGARDS),纳入基线无卒中与痴呆、年龄≥45岁的42342名参与者,中位认知随访11.1年、痴呆观察397344人年。首次明确缺血性卒中按NIHSS分为0-5、6-10、≥11三组,与无卒中者相比,痴呆调整HR分别为1.93、3.26、5.06。卒中严重程度越高,整体认知、记忆与执行功能下降越陡,整体认知从无卒中者每年-0.18分至中重度卒中者每年-0.58分。作者认为应重视卒中预防、尤其重度卒中,并探寻卒中与认知下降之间的机制。

要点

  • 与无卒中者相比,缺血性卒中后痴呆调整HR:NIHSS 0-5为1.93(95%CI 1.52-2.45),NIHSS 6-10为3.26(95%CI 1.93-5.53),NIHSS≥11为5.06(95%CI 2.71-9.45)。
  • 整体认知年下降幅度:无卒中者-0.18分/年(95%CI -0.19至-0.18),中重度卒中者-0.58分/年(95%CI -0.73至-0.42)。
  • 记忆年下降幅度:无卒中者-0.15分/年(95%CI -0.16至-0.14),中重度卒中者-0.36分/年(95%CI -0.51至-0.21)。
  • 执行功能年下降幅度:无卒中者-0.33分/年(95%CI -0.34至-0.32),中重度卒中者-0.52分/年(95%CI -0.66至-0.39)。
  • 卒中严重程度越高,整体认知、记忆与执行功能下降越陡,整体认知与记忆的剂量-反应关联更明显。

适用人群与场景

  • 3个美国前瞻性队列(ARIC 1987-2019、Framingham后代研究 1971-2019、REGARDS 2003-2019)中年龄≥45岁、基线无卒中与痴呆的参与者,共42342人(平均年龄61.3岁,55.0%女性)。
  • 首次明确缺血性卒中幸存者中,1055/1505人(70.1%)有卒中严重程度数据。

诊断标准与关键阈值

  • 缺血性卒中严重程度按美国国立卫生研究院卒中量表(NIHSS)分组:轻度(NIHSS 0-5)、轻至中度(NIHSS 6-10)、中至重度(NIHSS≥11)。
  • 首次明确缺血性卒中由各队列按统一方案报告。

研究设计与关键结果

  • 研究类型:3个美国前瞻性队列汇总的队列研究;样本量42342人;中位认知随访11.1年(范围0-29.7年),痴呆观察397344人年。
  • 与无卒中者相比,痴呆调整HR:NIHSS 0-5为1.93(95%CI 1.52-2.45),NIHSS 6-10为3.26(95%CI 1.93-5.53),NIHSS≥11为5.06(95%CI 2.71-9.45)。
  • 整体认知年变化:无卒中者-0.18分/年(95%CI -0.19至-0.18),中重度卒中者-0.58分/年(95%CI -0.73至-0.42);记忆:无卒中者-0.15分/年(95%CI -0.16至-0.14),中重度卒中者-0.36分/年(95%CI -0.51至-0.21);执行功能:无卒中者-0.33分/年(95%CI -0.34至-0.32),中重度卒中者-0.52分/年(95%CI -0.66至-0.39)。
  • 卒中严重程度越高,整体认知、记忆与执行功能下降越陡,整体认知与记忆的剂量-反应关联更明显。

证据类型、等级与局限

  • 证据类型:3个美国前瞻性队列汇总的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现强调卒中预防、尤其是重度卒中预防至关重要,并应识别可能连接卒中与认知下降的机制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The association between stroke severity and dementia is well established. However, reports on trajectories of cognitive decline comparing stroke survivors with individuals without stroke in large cohorts are insufficient.

OBJECTIVES: To examine associations of ischemic stroke incidence and severity with cognitive decline and dementia risk and to explore whether vascular risk factors modify these associations.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study pooled longitudinal data on cognitive function of participants aged 45 years or older and without stroke and dementia at baseline from 3 US prospective cohorts: the Atherosclerosis Risk in Communities study (1987-2019), Framingham Offspring Study (1971-2019), and Reasons for Geographic and Racial Differences in Stroke study (2003-2019). First definite ischemic strokes were reported in each cohort using consistent protocols, with severity defined using the National Institutes of Health Stroke Scale (NIHSS). The data analysis was completed February 27, 2026.

EXPOSURE: Incident ischemic stroke categorized as minor (NIHSS 0-5), mild to moderate (NIHSS 6-10), or moderate to severe (NIHSS ≥11).

MAIN OUTCOMES AND MEASURES: The primary outcomes were decline in global cognition and incident dementia. Secondary outcomes were changes in memory and executive function. Multivariable linear mixed-effects models were used to test the association of stroke incidence and severity with cognitive decline.

RESULTS: A total of 42 342 participants from the pooled cohorts were included (mean [SD] age, 61.3 [9.8] years; 55.0% female). Longitudinal cognitive testing data were available for a median of 11.1 years (range, 0-29.7 years) with 397 344 person-years of observation for dementia incidence. Stroke severity data were available for 1055 of 1505 first-ever ischemic stroke survivors (70.1%). Compared with participants with no stroke, adjusted hazard ratios for incident dementia were 1.93 (95% CI, 1.52-2.45) for NIHSS 0 to 5, 3.26 (95% CI, 1.93-5.53) for NIHSS 6 to 10, and 5.06 (95% CI, 2.71-9.45) for NIHSS 11 or higher. Over the follow-up, higher stroke severity was associated with progressively steeper cognitive declines across all domains, with more prevalent dose-response associations for global cognition (ranging from a mean -0.18 [95% CI, -0.19 to -0.18] points per year for no stroke to -0.58 [95% CI, -0.73 to -0.42] points per year for moderate to severe stroke) and memory (ranging from a mean -0.15 [95% CI, -0.16 to -0.14] points per year for no stroke to -0.36 [95% CI, -0.51 to -0.21] points per year for moderate to severe stroke) than for executive function (ranging from a mean -0.33 [95% CI, -0.34 to -0.32] points per year for no stroke to -0.52 [95% CI, -0.66 to -0.39] points per year for moderate to severe stroke).

CONCLUSIONS AND RELEVANCE: This large cohort study of participants from 3 prospective cohorts found that greater stroke severity was associated with substantially elevated dementia risk and accelerated decline in global cognition, memory, and executive function. These findings underscore the critical importance of stroke prevention, particularly severe stroke, and identifying mechanisms that may link stroke to cognitive decline.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Koton S, Gross AL, Aparicio HJ, et al. Ischemic Stroke Incidence and Severity and Poststroke Cognitive Decline and Incident Dementia. JAMA Netw Open. 2026. PMID: 41989779. doi:10.1001/jamanetworkopen.2026.8900

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。